Purpose: Cardiac carcinoma is the most common subtype of gastric cancer and its incidence has increased in recent years. e current chemotherapeutic drugs exhibit limited e ectiveness and signi cant side e ects in patients. Maslinic acid (MA) exerts an antitumor activity on a wide range of cancers and has no signi cant side e ect; however, the anti-tumor e ect of MA on cardiac carcinoma has not yet been explored.
Cardiac carcinoma (also called carcinoma of the gastric cardia) is an adenocarcinoma that origins from the epithelial cells located in the connection between stomach and esophagus and is among the most common types of gastric cancer. Although surgery is still the most e ective regimen for cardiac carcinoma, it is not e ective for patients at the late stages of the disease, especially when metastasis has already occurred [1] . Chemotherapy exhibits some e ectiveness in the treatment of metastatic cardiac carcinoma [1] ; however, the e ectiveness of current drugs is too limited to prolong the survival of the patients. Furthermore, current drugs also induce toxicity in normal tissues [1] . Novel compounds that exert anti-tumor activity on cardiac carcinoma cells without toxic side e ects are needed.
Maslinic acid (MA) is a naturally occurring pentacyclic triterpene and is isolated from a wide range of edible and medicinal plants. MA has been shown to exert anti-tumor activity on some types of cancer [2] , including melanoma [3] , prostate cancer [4] , hepatocellular carcinoma [5] and intestinal cancer [6, 7] . Previous studies have demonstrated that MA can induce apoptosis in cancer cells [2, 8] . In addition, MA has no cytotoxicity to normal cells, which limits side e ects when used for cancer treatment [9] . e ability of MA to suppress cardiac carcinoma growth has not yet been tested. In this study, several cardiac cancer cell lines and specimens from patients were employed to study the e ect of MA on cardiac carcinoma and to ascertain the mechanisms involved.
Materials and Methods

Compounds
Maslinic acid (MA) was generously provided by Dr. Zhang (Yunnan Agriculture University, Kunming, China). e molecular weight of MA is 472 Daltons. MA was dissolved with DMSO at a concentration of 10 mM and diluted to the indicated concentrations when needed.
Cell cultures
Human carcinoma of gastric cardia cell lines, SGC-7901 and BGC-823, and normal human liver cells, L-02, were purchased from Shanghai Cell Collection (Shanghai, China). Normal human lung broblast cell line, MRC-5, was purchased from American Type Culture Collection (ATCC, Manassas,VA, USA). e cells were all cultured in the recommended media (ATCC-formulated Eagle's Minimum Essential Medium for MRC-5; RPMI-1640 for SGC-7901, BGC-823 and L-02; all media was purchased from Life Technologies, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS, Life Technologies) and 5 mM glutamine in a 5% CO2-containing humidi ed atmosphere at 37°C.
Primary culture e protocols have been approved by Human Investigations or Ethics Committee in Zhengzhou University (Zhengzhou, China). Cardiac carcinoma specimens were obtained from the patients in the Department of Gastroenterology, the First Afliated Hospital of Zhengzhou University (Zhengzhou, China). e specimens were placed in 20% FBS-containing media, minced with scissors and digested for at least 1 h. e cells were centrifuged at 800 rpm for 15 min, resuspended in RPIM-1640 media with 20% FBS and cultured at 37! in a humidi ed atmosphere of 5% CO2 for 24 h. e supernatant was discarded and replaced with fresh RPIM-1640 media with 20% FBS then primary cancer cells were cultured following routine procedures. No mycoplasma was detected in the primary cultures.
MTT assays
Indicated cells (1×10 4 cells) were seeded in each well of 96-well plates. Overnight, compounds at the indicated concentrations were added to each well and 24 h later, 50 μl 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 1μg/ml) was added to each well. A er 4 h, the media was removed and 150 μl DMSO were added to each well. Spectrophotometric absorbance of the samples was measured with Microplate Reader Model 550 (Bio-Rad Laboratories, city, Japan) at 570 nm with a reference wavelength of 655 nm. e percentage of living cells was calculated using the following formula: cell survival rate = absorbance value of infected cells / absorbance value of uninfected cells. Eight reduplicate wells were measured at each concentration and all experiments were performed at least three times.
Animal experiments
Procedures for animal experiments were approved by the Committee on the Use and Care on Animals of Zhengzhou University (Zhengzhou, China). Brie y, 5×10 6 SGC-7901 cells were subcutaneously injected into the anks of 4-week-old male BALB/c nude mice. When tumors reached nearly 7-9 mm in diameter, 21 mice were randomly split into three groups: control group, low concentration (5 mg/kg) MA group and high concentration (20 mg/kg) MA group (n=7 for each group). MA was intraperitoneally administrated every other day until experiments were nished. Tumor diameter was measured by periodic measurements with calipers and volume 
Immunoblot assays
Total proteins were extracted from cells with M-PER ® Mammalian Protein Extraction Reagent ( ermo Scienti c, Rockford, IL, USA). Mitochondria were isolated from cells using the Mitochondria Isolation Kit ( ermo Scienti c) and mitochondrial proteins were extracted using M-PER ® Mammalian Protein Extraction Reagent ( ermo Scienti c). P roteins was separated with 10-12% polyacrylamide gel electrophoresis and transferred onto 0.45 μm nitrocellulose membranes. e membranes were blocked with 5% fat-free dry milk in PBS and incubated with primary antibodies. e membrane was incubated with corresponding secondary antibodies and visualized with SuperSignal West Dura Extended Duration Substrate ( ermo Scienti c). e involved antibodies include phos-p38 MAPK (1:1000), p38 MAPK (1:1000), cytochrome C (1:1000), COX (1:1000), cleaved caspase 9 (1:1000), cleaved caspase 3 (1:1000), cleaved PARP (1:1000) and GAPDH (1:2000) . ese antibodies were all purchased from Cell Signaling Technology (Beverly, MA, USA). e quanti cation of blot intensity was performed using ImageJ so ware (Version 1.47).
MMP evaluation
e change in mitochondrial membrane potential (MMP) in the indicated cells was detected using JC-1 staining based on ow cytometry (Invitrogen Life Technologies, Grand Island, NY, USA), following the manufacturer's procedures. A er 24 h incubation of MA, the cells were washed with PBS three times and then resuspended in PBS at the concentration of 1× 10 6 cells/ml. e cells were stained with 4 μl JC-1 (1 mg/ml) in a dark room at 37 °C for 1 h. e JC-1 positive cells were detected by ow cytometer (Aria II, BD Biosciences, San Jose, CA, USA).
Apoptosis detection
Propidium iodide (PI) staining was used to quantify the apoptotic rates of cardiac carcinoma cells treated with MA. Cells (3.5×10 5 ) were cultured in each well of 6-well plates. Overnight, the cells were treated with MA and 24 h later the media was replaced with PBS and the cells were stained with PI (50 mg/ml) (BD Biosciences). e percentage of Sub G 0 /G 1 population, which represents apoptotic cells, was analyzed using cytometrical analysis (Aria II, BD Biosciences).
Blocking of the p38 MAPK pathway
e cells were pretreated with SB203580 (10 μM, Cell Signaling Technology) 1 h prior to MA treatment. Subsequent experiments were performed to detect the survival, p-38 MAPK expression, MMP and apoptotic rates of cardiac carcinoma cells, following the procedures described elsewhere.
Statistical analysis
Each experiment was performed at least three times. All values were reported as means ± SD and compared at a given time point using an unpaired, two-tailed Student's t-test. Data were considered to be statistically signi cant when p < 0.05 (*) and p < 0.01 (**).
Results
MA reduced the viability of cardiac carcinoma cells
e stereochemical structure of maslinic acid (MA) was shown in Fig. 1 . First, the e ect of MA on the survival of cardiac carcinoma cells was examined. e viability of the cell lines derived from carcinoma of gastric cardia, SGC-7901 and BGC-823, as well as the primary cancer cells from cardiac carcinoma patients, was found to be reduced by MA in a dose-dependent fashion ( Fig. 2A) . In addition, DMSO exhibited some cytotoxicity to SGC-7901 cells at high concentrations (Fig. 2B) . In contrast, the survival of normal cells, and Het-1A, MRC-5 and L-02 cells, was not a ected until the dose of MA exceeded 100 μM (Fig. 2C ). e IC50 values were listed in Table 1 . e above data showed that MA's cytotoxicity exhibited a relative selectivity for cardiac carcinoma cells.
MA reduced the growth of cardiac carcinoma xenogra s in vi o
e e ect of MA on the growth of cardiac carcinoma was evaluated in mice. SGC-7901 cells were subcutaneously injected into the anks of nude mice to establish a tumor model. MA was intraperitoneally injected at two di erent doses (5 mg/kg and 20 mg/kg) every other day. e results indicated that MA administration reduced the growth of tumor xenogra s in a dose-dependent way, and high concentration of MA was able to suppress the growth of cancer xenogra by approximately 50% (Fig. 3A) . e measurement of tumor weights also con rmed the inhibitory e ect of MA on SGC-7901 xenogra growth (Fig. 3B ).
p38 MAPK signaling was activated in cardiac carcinoma cells treated with MA
e mechanisms by which MA exerted it anti-tumor activity on cardiac carcinoma were investigated. Immunoblot analysis revealed that the phosphorylation of p38 MAPK was greatly increased in cancer cells treated with MA in both a dose-and time-dependent manner, suggesting that p38 MAPK signaling was activated by this stimulation (Fig. 4A and 4B ).
Mitochondria-dependent apoptosis was triggered by MA in cardiac carcinoma cells
Considering that p38 MAPK is a major inducer of apoptotic pathway in cancer cells, MA was studied to determine if it induced apoptosis in carcinoma of gastric cardia. e evaluation of mitochondria membrane potential (MMP) in SGC-7901 cells revealed that MA treatment reduced MMP in cardiac carcinoma cells (Fig. 5A) . Consistently, immunoblot assays revealed that pro-apoptotic protein, cytochrome C, was released into the cytosol from mitochondria under MA treatment (Fig.  5B) .
Subsequent experiments indicated that the cleavages of caspase 3 and PARP also occurred in SGC-7901 cells treated with MA (Fig. 6A) . Finally, MA-triggered apoptosis was conrmed in cardiac carcinoma cells by ow cytometrical analysis of the sub-G0/G1 population (Fig. 6B ).
e activation of the p38 MAPK pathway mediated the e ect of MA on carcinoma of gastric cardia
To con rm the importance of p38 MAPK activation for MA's anti-tumor activity on SGC-7901 cells, SB203580 was used to inhibit the activation of this signaling (Fig. 7A) . SB203580 greatly increased both the viability and MMP of SGC-7901 cells under the treatment of MA (Fig. 7B and 7C ). Consistent with this observation, apoptosis was found to be inhibited by SB203580 suppression of p38 MAPK signaling in cardiac carcinoma cells treated with MA (Fig. 7D) . Collectively, these data suggest that p38 MAPK-mediated activation of the endogenous apoptotic pathway is indispensable for the antitumor activity of MA. 
Discussion
Although the anti-tumor activity of MA has been veri ed in some types of cancer [10] , it is still unknown if this natural compound can induce apoptosis in cardiac carcinoma. In this study, the e ect of MA on the survival of cardiac carcinoma cells was investigated through multiple approaches. Our results revealed that MA induced apoptosis in cardiac carcinoma cells by activating p38 MAPK signaling. Actually, the induction of apoptosis has been documented to be one of the major mechanisms underlying the anti-tumor activity of MA. e apoptotic pathway can be triggered by MA, both in mitochondriadependent and -independent ways [8, 11] . e association of p38 MAPK signaling with MA's anti-tumor activity has also been indicated in previous studies. Wu et al. have shown that MA elicits apoptosis in salivary gland cancer cells by activating the Ca 2+ /p38 MAPK pathway [12] . Furthermore, some other compounds have also been reported to induce apoptosis in gastric cancers by activating the p38 MAPK pathway, such as calebin-A [13] , and phenethyl isothiocyanate [14] . Although our studies showed that MA induces apoptosis by activating the p38 MAPK pathway, the possibility cannot be excluded that some other pathways may be also involved with the pro-apoptotic activity of MA. Some studies demonstrated that MA can also trigger the apoptotic pathway in cancer cells by JNK and NF-κB pathways [11, 15] .
In conclusion, MA was shown to suppress the growth of cardiac carcinoma by inducing p38 MAPK-dependent apoptosis. is natural compound, and its derivatives, may be promising anti-tumor agents for cardiac carcinoma treatment in future.
